Question · asked by 1 review

Rotarix vs placebo: Severe cases of rotavirus diarrhoea

Rotarix leads to lower severe cases of rotavirus diarrhoea compared with placebo (high certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Rotarix vs placebo
Severe cases of rotavirus diarrhoea · children
Rotarix leads to lower severe cases of rotavirus diarrhoea compared with placebo (high certainty).
Vaccines for preventing rotavirus diarrhoea: vaccines in use (2021) · Cochrane Headline outcomes only
RR 0.07 [0.03, 0.18]4 studies · 14976 participantsHigh
Rotarix vs placebo
Severe cases of rotavirus diarrhoea · children
Rotarix leads to lower severe cases of rotavirus diarrhoea compared with placebo (high certainty).
Vaccines for preventing rotavirus diarrhoea: vaccines in use (2021) · Cochrane Headline outcomes only
RR 0.42 [0.28, 0.61]4 studies · 15822 participantsHigh
Rotarix vs placebo
Severe cases of rotavirus diarrhoea · children
Rotarix probably leads to lower severe cases of rotavirus diarrhoea compared with placebo (moderate certainty).
Vaccines for preventing rotavirus diarrhoea: vaccines in use (2021) · Cochrane Headline outcomes only
RR 0.65 [0.51, 0.83]2 studies · 13768 participantsModerate
Rotarix vs placebo
Severe cases of rotavirus diarrhoea · children
Rotarix leads to lower severe cases of rotavirus diarrhoea compared with placebo (high certainty).
Vaccines for preventing rotavirus diarrhoea: vaccines in use (2021) · Cochrane Headline outcomes only
RR 0.1 [0.07, 0.14]6 studies · 18145 participantsHigh
Rotarix vs placebo
Severe cases of rotavirus diarrhoea · children
Rotarix leads to lower severe cases of rotavirus diarrhoea compared with placebo (high certainty).
Vaccines for preventing rotavirus diarrhoea: vaccines in use (2021) · Cochrane Headline outcomes only
RR 0.21 [0.16, 0.29]4 studies · 31671 participantsHigh
Rotarix vs placebo
Severe cases of rotavirus diarrhoea · children
Rotarix leads to lower severe cases of rotavirus diarrhoea compared with placebo (high certainty).
Vaccines for preventing rotavirus diarrhoea: vaccines in use (2021) · Cochrane Headline outcomes only
RR 0.23 [0.17, 0.29]3 studies · 23834 participantsHigh

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Vaccines for preventing rotavirus diarrhoea: vaccines in use
2021 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.